Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance

Clinical and Experimental Immunology

Volumn 150, Issue 2, 2007, Pages 312-321

  Preuss B ^a   Berg, C ^a   Altenberend, F ^a   Gregor, M ^a   Stevanovic, S ^a   Klein, R ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Anti mitochondrial antibodies; Autoantibodies; Chronic liver diseases; Human sulphite oxidase

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; MITOCHONDRION ANTIBODY; SULFITE OXIDASE; URSODEOXYCHOLIC ACID;

ADULT; AGED; ANALYSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; INCIDENCE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHOLANGITIS, SCLEROSING; CHRONIC DISEASE; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SULFITE OXIDASE;

EID: 35348984558     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03482.x     Document Type: Article

References (50)

1. Berg PA, Klein R. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance. Dig Dis Sci 1992 10 : 85 102.
2. Berg PA, Klein R. Mitochondrial antigen/antibody systems in primary biliary cirrhosis: revisited. Liver 1995 15 : 281 92.
3. Berg PA, Klein R, Lindenborn-Fotinos J, Klöppel G. ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet 1982 ii : 1423 5.
4. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70kD mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987 138 : 3525 31.
5. Yeaman SP, Fussey SPM, Danner DJ, James OFW, Mutimer DJ, Bassendine MF. Identification of two major M2 mitochondrial antigens. Lancet 1988 i : 1067 70.
6. Weber P, Brenner J, Stechemesser E et al. Characterization and clinical relevance of a new complement fixing antibody - anti-M8 - in patients with primary biliary cirrhosis. Hepatology 1986 6 : 553 9.
7. Klein R, Berg PA. Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space. Clin Exp Immunol 1991 84 : 445 8.
8. Bunn CC, McMorrow M. Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies. Clin Exp Immunol 1995 102 : 131 6.
9. Davis PA, Leung PS, Manns MP et al. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena? Hepatology 1992 16 : 1128 36.
10. Palmer JM, Yeaman SJ, Bassendine MF, James OFW. M4 and M9 autoantigens in primary biliary cirrhosis - a negative study. J Hepatol 1993 18 : 251 4.
11. Kisker C, Schindelin H, Pacheco A et al. Molecular basis of sulfite oxidase deficiency from the structure of sulfite oxidase. Cell 1997 91 : 973 83.
12. Preuß B, Altenberend F, Dengjel J, Motunova N, Stevanovic S, Klein R. Sulfite oxidase - a new antigen system in cryptogenic liver disorders? Immunobiology 2005 210 : 423 [Abstract].
13. Preuß B, Berg C, Altenberend F, Gregor M, Stevanovic S, Klein R. The mitochondrial enzyme sulfite oxidase - a new antigen/antibody system in primary sclerosing cholangitis (PSC): specificity and clinical implications. Hepatology 2006 44 (4 Suppl. 1 263A.
14. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999 31 : 929 38.
15. Perkins DN, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999 20 : 3551 67.
16. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996 68 : 850 8.
17. Berg PA, Doniach D, Roitt IM. Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J Exp Med 1967 126 : 277 90.
18. Klein R, Eisenburg J, Weber P, Seibold F, Berg PA. Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology 1991 14 : 1147 52.
19. Lindenborn-Fotinos J, Baum H, Berg PA. Mitochondrial antibodies in primary biliary cirrhosis. Further characterization of the M2-antigen by immunoblotting, revealing species and non-species specific determinants. Hepatology 1985 5 : 763 9.
20. Klein R, Pointner H, Zilly W et al. Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver 1997 17 : 119 28.
21. Laemmli U. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970 227 : 680 5.
22. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979 76 : 4350 4.
23. Terjung B, Spengler U. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases. Clin Rev Allergy Immunol 2005 28 : 115 33.
24. Beuers U, Rust C. Overlap syndromes. Semin Liver Dis 2005 25 : 311 20.
25. Floreani A, Rizzotto ER, Ferrara F et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 2005 100 : 1516 22.
26. Gheorghe L, Iacob S, Gheorghe C et al. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease. Eur J Gastroenterol Hepatol 2004 16 : 585 92.
27. van Buuren HR, van Hoogstraten HJE, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 2000 33 : 543 8.
28. Kingham JGC, Abbasi A. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective. Eur J Gastroenterol Hepatol 2005 17 : 1077 80.
29. Bansi D, Chapman R, Fleming K. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titer, specificity and IgG subclass. J Hepatol 1996 24 : 581 6.
30. Claise C, Johanet C, Bouhnik Y, Kapel N, Homberg JC, Poupon R. Antineutrophil cytoplasmic antibodies in autoimmune liver and inflammatory bowel diseases. Liver 1996 16 : 28 34.
31. Duerr RH, Targan SR, Landers CL et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991 100 : 1385 91.
32. Hardarson S, Labrecque DR, Mitros FA, Neil GA, Goeken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. Am J Clin Pathol 1993 99 : 277 81.
33. Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993 17 : 411 7.
34. Seibold F, Weber P, Klein R, Berg PA, Wiedmann K-H. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992 33 : 657 62.
35. Targan SR, Landers CL, Vidrich A, Czaja AJ. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 1995 108 : 1159 66.
36. Zauli D, Ghetti S, Grassi A et al. Anti-neutrophil cytoplasmic antibodies in type 1 and type 2 autoimmune hepatitis. Hepatology 1997 25 : 1105 7.
37. Berg PA, Klein R. Investigation of the specific autoantigen of primary sclerosing cholangitis by Western blot and immunoprecipitation. Hepatology 1993 18 : 471 3.
38. Lo SK, Chapman RW, Fleming KA. Investigation of the specific autoantigen of primary sclerosing cholangitis by Western blot and immunoprecipitation. Hepatology 1993 18 : 469 71.
39. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanism of action and therapeutic use revisited. Hepatology 2002 36 : 525 31.
40. Zuchner D, Sternsdorf T, Szostecki C, Heathcote J, Cauch-Dudek K, Will H. Prevalence, kinetics and therapeutic modulation of autoantibodies against sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 1997 26 : 1123 30.
41. Joshi VC, Ramakrishna Kurup CK, Ramasarma T. The cryptic nature of hepatic microsomal sulphite oxidase. Biochem J 1969 111 : 297 301.
42. Kluck RM, Esposti MD, Perkins G et al. The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol. J Cell Biol 1999 147 : 809 22.
43. Patterson SD, Spahr CS, Daugas E et al. Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition. Cell Death Differ 2000 7 : 137 44.
44. Bellentani S. Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go? Eur J Gastroenterol Hepatol 2005 17 : 137 40.
45. Brokx SJ, Rothery RA, Zhang G, Ng DP, Weiner JH. Characterization of an Escherichia coli sulfite oxidase homologue reveals the role of a conserved active site cysteine in assembly and function. Biochemistry 2005 44 : 10339 48.
46. Campbell WH. Nitrate reductase structure, function and regulation: bridging the gap between biochemistry and physiology. Annu Rev Plant Physiol Plant Mol Biol 1999 50 : 277 303.
47. Hille R. Plants have SOX: the structure of sulfite oxidase from Aradopsis thaliana. Structure 2003 11 : 1189 90.
48. Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 1986 63 : 127 34.
49. Maran R, Dueymes M, Le Corre R, Renaudineau Y, Shoenfeld Y, Youinou P. IgG subclasses of human autoantibodies. Ann Med (Paris) 1997 148 : 29 38.
50. Sammaritano LR, Ng S, Sobel R et al. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis. Arthritis Rheum 1997 40 : 1998 2006.